VA secretary defends use of hydroxychloroquine for veterans, claims analysis led to ‘misinformation’

Veterans Affairs (VA) Secretary Robert Wilkie on Wednesday defended the department’s use of an unproven anti-malaria drug for treating patients with COVID-19, the disease caused by the novel coronavirus, saying that the drug was only being administered for high-risk veterans. In a letter sent to veterans organizations, Wilkie claimed that a recent analysis of those hospitalized in Veterans Health Administration medical centers led to “…